ADAPTIVE-CHANGES IN 5-HT1A RECEPTOR-MEDIATED HIPPOCAMPAL INHIBITION IN THE ALERT RAT PRODUCED BY REPEATED 8-OH-DPAT TREATMENT

被引:12
作者
MANAHANVAUGHAN, D
ANWYL, R
ROWAN, MJ
机构
[1] UNIV DUBLIN,DEPT PHARMACOL & THERAPEUT,DUBLIN 2,IRELAND
[2] UNIV DUBLIN,DEPT PHYSIOL,DUBLIN 2,IRELAND
关键词
5-HT; (5-HYDROXYTRYPTAMINE; SEROTONIN); 5-HT1A RECEPTORS; 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN (8-OH-DPAT); HIPPOCAMPUS; EXCITATORY POSTSYNAPTIC POTENTIAL (EPSP); REPEATED TREATMENT; ANXIOLYTIC; ANTIDEPRESSANT;
D O I
10.1111/j.1476-5381.1994.tb13194.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The effect of acute and repeated treatment with 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a 5-HT1A, receptor ligand, on excitatory amino acid-mediated synaptic transmission was examined in the stratum radiatum CA1 region of the dorsal hippocampus of alert, gently restrained, rats. 2 Acute administration of 8-OH-DPAT transiently reduced the amplitude of the field excitatory postsynaptic potential (e.p.s.p.) in a dose-dependent (25-75 mu g kg(-1), i.p.) manner. This effect was blocked by the postsynaptic 5-HT1A receptor antagonist, MDL 73005EF (2 and 4 mg kg(-1), i.p.). 3 8-OH-DPAT (25 mu g kg(-1), i.p.) administered daily for 7 days produced a gradual reduction in the 24 h pre-injection baseline field e.p.s.p. amplitude. The reduction reached its lowest level after 7-8 days and was transiently reversed by acute injection of MDL 73005EF (2 mg kg(-1), i.p.) on day 8. The field e.p.s.p. baseline amplitude recovered fully 5-8 days after cessation of drug treatment. 4 8-OH-DPAT (25 mu g kg(-1), i.p.) administered daily for 7 days produced a marked reduction in acute response to 8-OH-DPAT (25 and 50 mu g kg(-1), i.p.) which did not recover until between day 36 and day 80 of the study. 5 It was concluded that repeated treatment with 8-OH-DPAT produced adaptive changes which resulted ill a reduction in the dynamic range of 5-HT1A receptor-mediated transmission in the hippocampus.
引用
收藏
页码:1083 / 1088
页数:6
相关论文
共 47 条
[31]   THE EFFECT OF PROLONGED TREATMENT WITH TRICYCLIC ANTIDEPRESSANTS ON THE ACTIONS OF 5-HYDROXYTRYPTAMINE IN THE HIPPOCAMPAL SLICE OF THE RAT [J].
ROWAN, MJ ;
ANWYL, R .
NEUROPHARMACOLOGY, 1985, 24 (02) :131-137
[32]  
ROWAN MJ, 1990, ANTIDEPRESSANTS 30 Y, P231
[33]  
SCHECHTER LE, 1990, J PHARMACOL EXP THER, V255, P1335
[34]   ANTI-CONFLICT EFFICACY OF BUSPIRONE FOLLOWING ACUTE VERSUS CHRONIC TREATMENT [J].
SCHEFKE, DM ;
FONTANA, DJ ;
COMMISSARIS, RL .
PSYCHOPHARMACOLOGY, 1989, 99 (03) :427-429
[35]   5-HT(1A) RECEPTOR LIGANDS IN ANIMAL-MODELS OF ANXIETY, IMPULSIVITY AND DEPRESSION - MULTIPLE MECHANISMS OF ACTION [J].
SCHREIBER, R ;
DEVRY, J .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1993, 17 (01) :87-104
[36]   PHARMACOKINETICS OF BUSPIRONE AS DETERMINED BY EXVIVO (3H)-DPAT BINDING [J].
SETHY, VH ;
FRANCIS, JW .
LIFE SCIENCES, 1988, 42 (10) :1045-1048
[37]  
SHARP T, 1993, N-S ARCH PHARMACOL, V348, P339
[38]   SUSTAINED 5-HYDROXYTRYPTAMINE RELEASE-INHIBITORY AND ANXIOLYTIC-LIKE ACTION OF THE PARTIAL 5-HT(1A) RECEPTOR AGONIST, BUSPIRONE, AFTER PROLONGED CHRONIC ADMINISTRATION [J].
SODERPALM, B ;
LUNDIN, B ;
HJORTH, S .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 239 (1-3) :69-73
[39]   RESPONSES OF HIPPOCAMPAL PYRAMIDAL CELLS TO PUTATIVE SEROTONIN 5-HT1A AND 5-HT1B AGONISTS - A COMPARATIVE-STUDY WITH DORSAL RAPHE NEURONS [J].
SPROUSE, JS ;
AGHAJANIAN, GK .
NEUROPHARMACOLOGY, 1988, 27 (07) :707-715
[40]   SEROTONERGIC INNERVATION OF THE HIPPOCAMPUS AND NUCLEUS-ACCUMBENS-SEPTI AND THE ANXIOLYTIC-LIKE ACTION OF MIDAZOLAM AND 5-HT(1A) RECEPTOR AGONISTS [J].
STEFANSKI, R ;
PALEJKO, W ;
BIDZINSKI, A ;
KOSTOWSKI, W ;
PLAZNIK, A .
NEUROPHARMACOLOGY, 1993, 32 (10) :977-985